Biotin Mouse Anti-human HLA-E Antibody *MEM-E/07, monoclonal*
HLA class I histocompatibility antigen, α chain E is a 40 kDa transmembrane protein that can be found in the plasma membrane, cell surface and extracellular space of cells. Sequencing of HLA class I histocompatibility antigen, α chain E has shown it contains 3 types of conserved structural units: extracellular, cytoplasmic and Ig-like C1-type domain. HLA class I histocompatibility antigen, α chain E takes part in processes such as immune response and natural killer cell mediated immunity. It promotes antibody-dependent cellular cytotoxicity, tumor necrosis factor production and TRAIL production conversely also inhibits natural killer cell mediated cytotoxicity. HLA class I histocompatibility antigen, α chain E is the subject of comprehensive study in part because of the fact that it is involved with the type I interferon signaling pathway and interferon-γ-mediated signaling pathway. HLA class I histocompatibility antigen, α chain E binds to MHC class I protein, signaling receptor and T cell receptor.
Conjugation
We provide custom conjugation services for this antibody (eg. labeling of HLA-E antibody with HRP). A list of available labels can be found in the table below:
For additional information about custom conjugations, please consult our services page here.
AF | AF350, AF488, AF555, AF594, AF647, AF680, AF700, AF750 |
Proteins | HRP, Alkaline Phosphatase, Streptavidin |
Tandems | APC, APC/Cy7, APC/AF750, APC/iFluor™ 700, APC/iFluor™ 750, PE, PE/Cy5, PE/Cy7, PE/AF610, PE/AF700, PE/iFluor™ 594, PE/iFluor™ 647, PE/iFluor™ 700, PE/iFluor™ 750, PE/Texas Red®, PerCP, PerCP/Cy5.5 |
Small Molecules | Biotin |
Traditional Dyes | FITC (fluorescein), TRITC, PacBlue, PacOrange, Cy3, Cy5 |
iFluor | 350, 405, 430, 450, 488, 514, 532, 546, 555, 560, 568, 594, 610, 633, 647, 660, 670, 680, 700, 710, 750, 790, 800, 810, 820, 840, 860, A7 |
mFluor | UV375, UV460, Violet 450, Violet 500, Violet 510, Violet 540, Blue 570, Green 620, Red 700, Red 780 |
For additional information about custom conjugations, please consult our services page here.
Page updated on December 17, 2024